Bell Ceremonies

Syndax Pharmaceuticals Rings the Nasdaq Stock Market Closing Bell

Published

Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Michael A. Metzger, Chief Executive Officer, rings the Closing Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now